Entero Healthcare Solutions reported a robust performance for the financial year ending March 31, 2026. The company achieved a 29.3% YoY increase in revenue to INR 6,591 crore, with EBITDA margins expanding to 4.0%. Strategic initiatives, including seven new acquisitions and a strengthened focus on the MedTech sector, have positioned the company for sustained long-term growth and market leadership in the fragmented healthcare supply chain.
FY26 Financial Performance
Entero Healthcare delivered significant financial improvements during the fiscal year. Reported revenue reached INR 6,591.2 crore, a 29.3% increase over the previous year. Operational efficiency drove EBITDA margins to 4.0%, up 67bps from 3.4% in FY25. The company also recorded a positive operating cash flow of INR 96.2 crore, reflecting improved working capital management.
Strategic Growth and MedTech Expansion
A key highlight of the year was the expansion into the MedTech segment, with three out of seven total acquisitions focused on this high-growth area. These strategic moves, including the acquisition of Anand Chemiceutics in Q4FY26, are projected to contribute over INR 1,000 crore to the company’s revenue in FY27. These acquisitions are expected to be margin-accretive, further strengthening the company’s long-term platform.
Operational Milestones
The company expanded its reach to 523 districts across India, supported by a network of 136 warehouses. Entero currently serves over 1,05,300 retail customers and 3,600 hospitals, maintaining strong relationships with more than 3,300 healthcare product manufacturers. By leveraging a proprietary technology platform and a robust hub-and-spoke distribution model, the company continues to outperform industry growth rates.
Outlook for FY27
Building on the momentum of FY26, the company has set clear guidance for FY27, targeting 23.0% YoY revenue growth and an EBITDA margin of 5.0%. Management remains focused on leveraging technology and scale to capture the significant consolidation opportunity within the Indian healthcare supply chain.
Source: BSE
